Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Revenue

Amphastar Pharmaceuticals had revenue of $676.21M in the twelve months ending March 31, 2024, with 30.38% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $171.84M with 22.72% year-over-year growth. In the year 2023, Amphastar Pharmaceuticals had annual revenue of $644.40M with 29.14% growth.

• Revenue (ttm): $676.21M
• Revenue Growth: +30.38%
• P/S Ratio: 2.86
• Revenue / Employee: $383,991
• Employees: 1,761
• Market Cap: 1.94B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	644.40M	145.41M	29.14%
Dec 31, 2022	498.99M	61.22M	13.98%
Dec 31, 2021	437.77M	87.92M	25.13%
Dec 31, 2020	349.85M	27.49M	8.53%
Dec 31, 2019	322.36M	27.69M	9.40%
Dec 31, 2018	294.67M	54.49M	22.69%
Dec 31, 2017	240.18M	-14.99M	-5.87%
Dec 31, 2016	255.17M	3.65M	1.45%
Dec 31, 2015	251.52M	41.06M	19.51%
Dec 31, 2014	210.46M	-19.22M	-8.37%
Dec 31, 2013	229.68M	25.36M	12.41%
Dec 31, 2012	204.32M	85.97M	72.63%
Dec 31, 2011	118.36M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.